Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
13(62%)
Results Posted
100%(2 trials)

Phase Distribution

Ph early_phase_1
1
5%
Ph phase_1
6
29%
Ph phase_2
11
52%
Ph phase_3
3
14%

Phase Distribution

7

Early Stage

11

Mid Stage

3

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
1(4.8%)
Phase 1Safety & dosage
6(28.6%)
Phase 2Efficacy & side effects
11(52.4%)
Phase 3Large-scale testing
3(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

13

trials recruiting

Total Trials

21

all time

Status Distribution
Active(17)
Completed(2)
Other(2)

Detailed Status

Recruiting9
Active, not recruiting4
Not yet recruiting3
Completed2
unknown2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
13
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (4.8%)
Phase 16 (28.6%)
Phase 211 (52.4%)
Phase 33 (14.3%)

Trials by Status

recruiting943%
completed210%
unknown210%
active_not_recruiting419%
enrolling_by_invitation15%
not_yet_recruiting314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07015242Phase 2

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Recruiting
NCT07621497Phase 2

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

Not Yet Recruiting
NCT07441369Phase 2

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Enrolling By Invitation
NCT07543744Phase 1

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

Recruiting
NCT07412613Phase 3

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Recruiting
NCT06544655Phase 1

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Active Not Recruiting
NCT05846867Phase 1

A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer

Active Not Recruiting
NCT07056777Phase 1

Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer

Recruiting
NCT06313801Phase 2

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Recruiting
NCT04245865Phase 2

Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

Active Not Recruiting
NCT04375605Phase 3

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

Active Not Recruiting
NCT06648525Phase 2

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Not Yet Recruiting
NCT06493760Phase 2

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

Recruiting
NCT06475326Phase 2

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Recruiting
NCT06531278Phase 2

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

Recruiting
NCT06478238Early Phase 1

Calcium Folinate Treatment of Spastic Paraplegia 56

Recruiting
NCT05480280Phase 2

mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer

Unknown
NCT05640726Phase 2

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Not Yet Recruiting
NCT01987102Phase 1

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Completed
NCT03258762Phase 1

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21